Capricor Therapeutics, Inc.
CAPR
$6.97
$0.081.16%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 151.52M | 85.03M | 29.46M | 39.92M | 39.49M |
Total Receivables | 10.37M | 409.70K | 370.00K | 369.00K | 10.37M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1.50M | 385.10K | 837.20K | 834.40K | 995.80K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | 291.40K | -- |
Total Current Assets | 163.39M | 85.82M | 30.67M | 41.41M | 50.86M |
|
|||||
Total Current Assets | 163.39M | 85.82M | 30.67M | 41.41M | 50.86M |
Net Property, Plant & Equipment | 6.87M | 6.81M | 7.29M | 7.74M | 7.61M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 221.70K | 319.20K | 319.60K | 293.70K | 268.20K |
Total Assets | 170.48M | 92.95M | 38.28M | 49.44M | 58.73M |
|
|||||
Total Accounts Payable | 8.18M | 6.52M | 6.16M | 6.24M | 6.24M |
Total Accrued Expenses | 10.00K | 10.00K | 10.00K | 10.00K | 10.00K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 834.80K | 813.60K | 792.70K | 771.50K | 749.10K |
Total Finance Division Other Current Liabilities | 12.00M | 13.13M | 15.39M | 19.36M | 24.27M |
Total Other Current Liabilities | 12.00M | 13.13M | 15.39M | 19.36M | 24.27M |
Total Current Liabilities | 21.03M | 20.48M | 22.35M | 26.38M | 31.27M |
|
|||||
Total Current Liabilities | 21.03M | 20.48M | 22.35M | 26.38M | 31.27M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 616.30K | 834.90K | 1.04M | 1.25M | 1.49M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 3.38M | 3.38M | 3.38M | 3.38M | 3.38M |
Total Liabilities | 25.02M | 24.69M | 26.78M | 31.01M | 36.13M |
|
|||||
Common Stock & APIC | 344.27M | 260.89M | 191.51M | 187.29M | 181.73M |
Retained Earnings | -199.83M | -192.72M | -180.16M | -169.16M | -159.37M |
Treasury Stock & Other | 1.03M | 96.20K | 155.00K | 307.70K | 235.80K |
Total Common Equity | 145.46M | 68.27M | 11.50M | 18.43M | 22.60M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 145.46M | 68.27M | 11.50M | 18.43M | 22.60M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 145.46M | 68.27M | 11.50M | 18.43M | 22.60M |
|